Usefulness of spironolactone in a specialized heart failure clinic.
暂无分享,去创建一个
Paul W Armstrong | P. Armstrong | F. McAlister | J. Ezekowitz | Justin Ezekowitz | Finlay A McAlister | W. Sligl | Wendy Sligl
[1] F. McAlister. Applying Evidence to Patient Care: From Black and White to Shades of Grey , 2003, Annals of Internal Medicine.
[2] S J Pocock,et al. Randomized trials or observational tribulations? , 2000, The New England journal of medicine.
[3] Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone: an analysis of 25 cases. , 2001, The American journal of medicine.
[4] S. Gottlieb,et al. Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. , 1998, The New England journal of medicine.
[5] J. McMurray,et al. Serious adverse events experienced by patients with chronic heart failure taking spironolactone , 2001, Heart.
[6] F. McAlister,et al. The effects of beta-blockers on morbidity and mortality in a population-based cohort of 11,942 elderly patients with heart failure. , 2002, The American journal of medicine.
[7] J. Cornuz,et al. Early uptake of research findings after fast-track publication , 2000, The Lancet.
[8] M. Jadoul,et al. Spironolactone and congestive heart-failure , 2000, The Lancet.
[9] Á. Cruz,et al. Hyperkalaemia in congestive heart failure patients using ACE inhibitors and spironolactone. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[10] P. Armstrong,et al. A systematic review of randomized trials of disease management programs in heart failure. , 2001, The American journal of medicine.
[11] T. Welte,et al. Interaction of spironolactone with ACE inhibitors or angiotensin receptor blockers: analysis of 44 cases , 2003, BMJ : British Medical Journal.
[12] R. Vanholder,et al. Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone: an analysis of 25 cases. , 2001, The American journal of medicine.
[13] E. Ofili,et al. Hyperkalemia in congestive heart failure patients aged 63 to 85 years with subclinical renal disease. , 2002, The American journal of cardiology.
[14] P. Armstrong,et al. The Use of -Blockers in a Tertiary Care Heart Failure Clinic , 2004 .
[15] A. Hartz,et al. A comparison of observational studies and randomized, controlled trials , 2000, American journal of ophthalmology.
[16] M. H. Schwenk,et al. Estimation of glomerular filtration rate to prevent life-threatening hyperkalemia due to combined therapy with spironolactone and angiotensin-converting enzyme inhibition or angiotensin receptor blockade. , 2002, The American journal of cardiology.
[17] B. Pitt,et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. , 1999, The New England journal of medicine.
[18] B. Pitt,et al. The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure , 2000 .
[19] B. Silke,et al. Spironolactone prescribing in heart failure: comparison between general medical patients and those attending a specialist left ventricular dysfunction clinic. , 2001, The Ulster medical journal.
[20] B. Pitt,et al. EPLERENONE POST-ACUTE MYOCARDIAL INFARCTION HEART FAILURE EFFICACY AND SURVIVAL STUDY INVESTIGATORS. EPLERENONE, A SELECTIVE ALDOSTERONE BLOCKER, IN PATIENTS WITH LEFT VENTRICULAR DYSFUNCTION AFTER MYOCARDIAL INFARCTION , 2003 .
[21] J. Concato,et al. Randomized, controlled trials, observational studies, and the hierarchy of research designs. , 2000, The New England journal of medicine.
[22] B. Bozkurt,et al. Complications of inappropriate use of spironolactone in heart failure: when an old medicine spirals out of new guidelines. , 2003, Journal of the American College of Cardiology.
[23] B. Pitt,et al. Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction , 2003 .